The U.S. Food and Drug Administration has approved another over-the-counter (OTC) intranasal naloxone product for the emergency treatment of opioid overdose. Consumers may directly purchase Rextovy, a 4 milligram naloxone hydrochloride nasal spray, without a prescription in places such as pharmacies, convenience stores, and online.
This action aligns with President Trump's Great American Recovery Initiative, a federal effort to address the country's addiction and substance use disorder crisis and coordinate the government's approach to prevention, treatment, and long-term recovery.
For comments and feedback contact: editorial@rttnews.com
Health News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.